Beschrijving

General


The long-term objective is to improve effectiveness of control programmes (i.e drug treatment and putative anti-schistosome vaccines), or alternatively, to promote immunoregulatory networks in individuals with severe morbidity.


Specific


To define innate immune responses in patients infected with schistosomes that are associated with down-regulation of acquired immune responses, or conversely the development of pathology.To characterise and manufacture parasite-derived immunoregulatory molecules.To use parasite-derived molecules to manipulate protective immune responses and immunopathology.To aid existing control programmes by using epidemiological and geographic data gathered in the field.
AcroniemSCHISTOINIR
StatusVoltooid
Effectieve start/einddatum1/11/0631/10/10

Financiering

  • European Commission: 249.000,00 €

ID: 1085981